Department of Anesthesiology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Pflugers Arch. 2013 Jul;465(7):921-7. doi: 10.1007/s00424-012-1211-y. Epub 2013 Jan 16.
Pain is an important clinical problem and, in its chronic form, may be a disabling condition. Most currently available therapies are insufficient and/or accompanied by serious side effects. Recent studies have implicated the CaV3.2 isoform of T-type Ca channels in nociceptive signaling. CaV3.2 channels are located in the somas of dorsal root ganglion cells and in the central endings of these cells in the dorsal horn of the spinal cord. These channels can support the development and maintenance of both physiological (nociceptive) and pathological (neuropathic) pain. In this review, we summarize the most recent evidence linking the presynaptic CaV3.2 channels to the etiology of neuropathic pain disorders. In particular, we focus on data linking plasticity of CaV3.2 channels with neuropathic pain disorders associated with mechanical peripheral nerve injury and with diabetic peripheral neuropathy. We also discuss the development of potential pain therapies aimed at these channels.
疼痛是一个重要的临床问题,其慢性形式可能导致身体残疾。目前大多数可用的治疗方法都不充分,而且/或者伴有严重的副作用。最近的研究表明 T 型钙通道的 CaV3.2 亚型在伤害性信号转导中起作用。CaV3.2 通道位于背根神经节细胞的胞体和脊髓背角中这些细胞的中枢末端。这些通道可以支持生理(伤害性)和病理(神经性)疼痛的发展和维持。在这篇综述中,我们总结了最近将 CaV3.2 通道与神经性疼痛障碍的病因联系起来的证据。特别是,我们关注与机械性周围神经损伤和糖尿病周围神经病变相关的神经性疼痛障碍与 CaV3.2 通道可塑性相关的数据。我们还讨论了针对这些通道开发潜在疼痛治疗方法的进展。